Qidni Labs, Inc., headquartered in Kitchener, Ontario is a Series A, clinical-stage medical device company disrupting the $100B kidney dialysis space. Qidni has developed a miniature dialysis system that is nearly waterless, portable, battery-powered, and connected to the cloud for remote monitoring. With this system, Qidni is able to drastically improve the global accessibility and environmental sustainability of dialysis, saving 10 million lives and 600 million cubic meters of drinking water per year. Qidni’s system makes treatment more cost-effective and equitable than any other treatment available on the market. The technology has been validated in long-term animal studies in fully nephrectomized sheep and the company is now initiating pilot clinical studies with dialysis patients.